Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER

Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
Drug Metabolism and Disposition July 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787
Hugo Girard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyne Villeneuve
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael H. Court
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis-Charles Fortier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Caron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qin Hao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa L. von Moltke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Greenblatt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Guillemette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 34 no. 7 1220-1228
DOI 
https://doi.org/10.1124/dmd.106.009787
PubMed 
16595709

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 18, 2006
  • Accepted March 29, 2006
  • Published online June 21, 2006.

Article Versions

  • Earlier version (April 4, 2006 - 10:10).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Hugo Girard,
  2. Lyne Villeneuve,
  3. Michael H. Court,
  4. Louis-Charles Fortier,
  5. Patrick Caron,
  6. Qin Hao,
  7. Lisa L. von Moltke,
  8. David J. Greenblatt and
  9. Chantal Guillemette
  1. Laboratory of Pharmacogenomics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier de l'Université Laval (CHUL) Research Center and Faculty of Pharmacy, Laval University, Quebec, Canada (H.G., L.V., L.-C.F., P.C., C.G.); and Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts (M.H.C., Q.H., L.L.v.M., D.J.G.)
  1. Address correspondence to:
    Chantal Guillemette, Canada Research Chair in Pharmacogenomics, Laboratory of Pharmacogenomics, CHUL Research Center, T3-48, 2705 Boul. Laurier, Quebec, QC, Canada, G1V 4G2. E-mail: chantal.guillemette{at}crchul.ulaval.ca
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to December 2023

AbstractFullPdf
Aug 20170137
Sep 201741411
Oct 20172187
Nov 20170334
Dec 20172250
Jan 20181338
Feb 20181166
Mar 20180248
Apr 20182192
May 201811412
Jun 20180244
Jul 2018063
Aug 20180181
Sep 20180302
Oct 20180482
Nov 20180642
Dec 201849132
Jan 20195723
Feb 20195633
Mar 20191707
Apr 2019913
May 2019818
Jun 2019606
Jul 20191722
Aug 20192706
Oct 20191803
Nov 20192631
Dec 20191812
Jan 20201471
Feb 20201501
Mar 20201510
May 20204021
Jun 20203212
Jul 20201003
Aug 20201022
Sep 20201412
Oct 20202200
Nov 20201121
Dec 20202301
Jan 20215183
Feb 20211081
Mar 20213745
Apr 20211220
May 20212152
Jun 20212320
Jul 20212011
Aug 20211035
Sep 2021931
Oct 2021521
Nov 20212120
Dec 20212821
Jan 2022710
Feb 20221023
Mar 20222120
Apr 20221883
May 2022910
Jun 20224710
Jul 20222329
Aug 20222320
Sep 20222411
Oct 20223332
Nov 20221554
Dec 20221632
Jan 20232841
Feb 20232111
Mar 2023812
Apr 20232722
May 20232036
Jun 2023521
Jul 20231226
Aug 2023653
Sep 20233335
Oct 2023410
Nov 20231713
Dec 2023610

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 34 (7)
Drug Metabolism and Disposition
Vol. 34, Issue 7
1 Jul 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER

Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
Drug Metabolism and Disposition July 1, 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVER

Hugo Girard, Lyne Villeneuve, Michael H. Court, Louis-Charles Fortier, Patrick Caron, Qin Hao, Lisa L. von Moltke, David J. Greenblatt and Chantal Guillemette
Drug Metabolism and Disposition July 1, 2006, 34 (7) 1220-1228; DOI: https://doi.org/10.1124/dmd.106.009787
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolism of HSK3486 in humans
  • A MDCKII-MDR1-BCRP cell line to assess efflux at the BBB
  • Influence of CYP3A5 on vincristine disposition and toxicity
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics